His pioneering work has taken him to Athens and Paris, Sydney and Montreal. Now scientist Vassilios Papadopoulos has come to Los Angeles to become dean of the USC School of Pharmacy.
As the executive director and chief scientific officer of the Research Institute of the McGill University Health Centre in Montreal, Papadopoulos facilitated international collaborations and the commercialization of technologies. For nearly a decade, he spearheaded research initiatives at the institute, including translational research and intervention across the lifespan, which secured more than $300 million in governmental grants to build an advanced clinical and biomedical research facility.
He received his doctorate in pharmacy from the University of Athens in Greece and holds a PhD in health and life science from the Université Pierre et Marie Curie in Paris. He was vice president for research at Georgetown University prior to joining McGill University. His decades of scholarship and research contributions include more than 300 published papers, numerous patents and roles on advisory committees around the world.
“The USC School of Pharmacy has a major role to play in the U.S. health care environment and in the future of health care delivery,” Papadopoulos says. “Together, the faculty, students and I will work to advance treatment and care for patients now and for many years to come.”